ConductScience.org, home

Paper42963333PubMed

Expert perspectives on the design and communication of endpoints in Alzheimer's disease clinical trials.

Tariot PN and 15 others. Alzheimers Dement, 2026.

Cite this record

ConductScience Library. Expert perspectives on the design and communication of endpoints in Alzheimer's disease clinical trials. Papers, record 42963333. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42963333

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Expert perspectives on the design and communication of endpoints in Alzheimer's disease clinical trials.
Journal
Alzheimers Dement
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-11-02

Source PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tariot PNPierre N
2Dickson SPSamuel P
3Dwyer JJohn
4Granda CCarlos
5Hughes LLynne
6Karlawish JJason
7Linz NNicklas
8Nair KVKavita V
9Paulsen RRuss
10Pawson DDaniel
11Perneczky RRobert
12Schindler SESuzanne E
13Scholler EEmily
14Taylor JJames
15Tiede BBenjamin
16Vradenburg GGeorge

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Clinical Trials as TopicMajor topic
Endpoint DeterminationMajor topic
CommunicationMajor topic
Research DesignMajor topic
Humans

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Bristol Myers SquibbPubMed

Source PubMed

Download CSV of grants

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138561021Minimal clinically important difference in Alzheimer's disease: Rapid review.Alzheimers Dement2024https://conductscience.org/library/papers/38561021PubMed
235440022Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease.Alzheimers Res Ther2022https://conductscience.org/library/papers/35440022PubMed
312954465Responsiveness of goal attainment scaling in a randomized controlled trial of comprehensive geriatric assessment.J Clin Epidemiol2003https://conductscience.org/library/papers/12954465PubMed
42691207Measurement of health status. Ascertaining the minimal clinically important difference.Control Clin Trials1989https://conductscience.org/library/papers/2691207PubMed
511936935Methods to explain the clinical significance of health status measures.Mayo Clin Proc2002https://conductscience.org/library/papers/11936935PubMed
636763306Assessing What Matters to People Affected by Alzheimer's Disease: A Quantitative Analysis.Neurol Ther2023https://conductscience.org/library/papers/36763306PubMed
741368997Validation status of cognitive digital assessments by the FDA BEST framework and context of use in preclinical AD studies: A systematic review.Alzheimers Dement2025https://conductscience.org/library/papers/41368997PubMed
83337672Reliability of the Washington University Clinical Dementia Rating.Arch Neurol1988https://conductscience.org/library/papers/3337672PubMed
940463637Alzheimer's disease drug development pipeline: 2025.Alzheimers Dement (N Y)2025https://conductscience.org/library/papers/40463637PubMed
1040225240Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?Alzheimers Dement (N Y)2025https://conductscience.org/library/papers/40225240PubMed
1138866966Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease.Nat Rev Neurol2024https://conductscience.org/library/papers/38866966PubMed
1238706269"Time Saved" Calculations to Improve Decision-Making in Progressive Disease Studies.J Prev Alzheimers Dis2024https://conductscience.org/library/papers/38706269PubMed
1330830492An overview of using qualitative techniques to explore and define estimates of clinically important change on clinical outcome assessments.J Patient Rep Outcomes2019https://conductscience.org/library/papers/30830492PubMed
1434295959Current advances in digital cognitive assessment for preclinical Alzheimer's disease.Alzheimers Dement (Amst)2021https://conductscience.org/library/papers/34295959PubMed
1537357301'Time Saved' As a Demonstration of Clinical Meaningfulness and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings.J Prev Alzheimers Dis2023https://conductscience.org/library/papers/37357301PubMed
1640348870A scoping review of remote and unsupervised digital cognitive assessments in preclinical Alzheimer's disease.NPJ Digit Med2025https://conductscience.org/library/papers/40348870PubMed
1739350367Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force.J Prev Alzheimers Dis2024https://conductscience.org/library/papers/39350367PubMed
1841330788Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extension.J Prev Alzheimers Dis2026https://conductscience.org/library/papers/41330788PubMed
1939949872Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer's disease.Alzheimers Dement (N Y)2025https://conductscience.org/library/papers/39949872PubMed
2024886908The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.JAMA Neurol2014https://conductscience.org/library/papers/24886908PubMed

See all 41 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42963333

GET https://conductscience.org/api/papers/v1/42963333/references?page=2